In recent years, GDF-15 has emerged as a promising biomarker, as it is involved in many of the pathological mechanisms underlying obesity, HF, and atherosclerosis [6,7]. This evidence concerns the gene GDF15 and obesity due to melanocortin 4 receptor deficiency.